Hurvitz Chaim
- SEC CIK
- 0001630542
No open-market purchases or sales filed in the past year.
Current role at each company
- NRXP NRX Pharmaceuticals, Inc.Directoras of Sep 10, 2025
- DROR Dror Ortho-Design, Inc.Directoras of Jun 25, 2024
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Hurvitz Chaim as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
NRXP NRX Pharmaceuticals, Inc.
Director2 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Sep 11, 2023 (view filing)9:15 AM ET | Aug 30 | 12 daysLate | Hurvitz ChaimDirector | PPurchaseCommon Stock, par value $0.001 per share | +70.0K | $0.2875 | +$20.1K | +14.0%570.0K after | |
| Nov 23, 2022 (view filing) | Nov 16-18 | 7 days | Hurvitz ChaimDirector | PPurchase | +500.0K | $1.03 | +$514.9K | New position500.0K after | Amended3 lots |